Authors: FENAUX P DEBOTTON S

Citation: P. Fenaux et S. Debotton, RETINOIC ACID SYNDROME - RECOGNITION, PREVENTION AND MANAGEMENT, Drug safety, 18(4), 1998, pp. 273-279

Authors: DEBOTTON S DOMBRET H SANZ M SANMIGUEL J CAILLOT D ZITTOUN R GARDEMBAS M STAMATOULAS A CONDE E GUERCI A GARDIN C GEISER K MAKHOUL DC REMAN O DELASERNA J LEFRERE F CHOMIENNE C CHASTANG C DEGOS L FENAUX P

Citation: S. Debotton et al., INCIDENCE, CLINICAL-FEATURES, AND OUTCOME OF ALL-TRANS-RETINOIC ACID SYNDROME IN 413 CASES OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 92(8), 1998, pp. 2712-2718

Authors: DEBOTTON S WATTEL E BAUTERS F FENAUX P

Citation: S. Debotton et al., LONG-TERM SURVIVAL AFTER INTENSIVE CHEMOTHERAPY IN DE-NOVO MDS - LILLES EXPERIENCE, Experimental hematology, 25(8), 1997, pp. 487-487

Authors: WATTEL E DEBOTTON S HEBBAR M MERLAT A BAUTERS F FENAUX P

Citation: E. Wattel et al., INTENSIVE CHEMOTHERAPY IN DE-NOVO MDS - OUTCOME OF PATIENTS WHO ACHIEVED PARTIAL REMISSION (PR), Experimental hematology, 25(8), 1997, pp. 488-488

Authors: WATTEL E DEBOTTON S LAI JL PREUDHOMME C LEPELLEY P BAUTERS F FENAUX P

Citation: E. Wattel et al., LONG-TERM FOLLOW-UP OF DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED WITHINTENSIVE CHEMOTHERAPY - INCIDENCE OF LONG-TERM SURVIVORS AND OUTCOMEOF PARTIAL RESPONDERS, British Journal of Haematology, 98(4), 1997, pp. 983-991

Authors: DEBOTTON S DOMBRET H SANZ M SANMIGUEL J CAILLOT D ZITTOUN R GARDEMBAS M STAMATOULAS A CONDE E GUERCI A GARDIN C MAKHOUL DC REMAN O DELASERNA J LEFRERE F CHASTANG C DEGOS L FENAUX P

Citation: S. Debotton et al., CLINICAL-FEATURES AND OUTCOME OF ATRA SYNDROME IN A LARGE MULTICENTERTRIAL IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL), Blood, 90(10), 1997, pp. 1477-1477